Looking to buy Intra-Cellular Therapies Stock? View today's ITCI stock price, trade commission-free, and discuss ITCI stock updates with the investor. Stock analysis for Intra-Cellular Therapies Inc (ITCI:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company. The 11 analysts with month price forecasts for ITCI stock have an average target of , with a low estimate of 74 and a high estimate of The average. View Intra-Cellular Therapies, Inc. ITCI stock quote prices, financial information, real-time forecasts, and company news from CNN. Get the latest updates on Intra-Cellular Therapies Inc. Common Stock (ITCI) pre market trades, share volumes, and more. Make informed investments with.
On average, Wall Street analysts predict that Intra Cellular Therapies's share price could reach $ by Aug 21, The average Intra Cellular Therapies. Get the latest Intra-Cellular Therapies Inc (ITCI) real-time quote, historical performance, charts, and other financial information to help you make more. 42 minutes ago. Intra-Cellular Therapies Stock (NASDAQ: ITCI) stock price, news, charts, stock research, profile. View the real-time ITCI price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees. View live Intra-Cellular Therapies Inc. chart to track its stock's price action. Find market predictions, ITCI financials and market news. Key Stats · Market CapB · Shares OutM · 10 Day Average VolumeM · Dividend- · Dividend Yield- · Beta · YTD % Change In depth view into ITCI (Intra-Cellular Therapies) stock including the latest price, news, dividend history, earnings information and financials. View a financial market summary for ITCI including stock price quote, trading volume, volatility, options volume, statistics, and other important company. See the latest Intra-Cellular Therapies Inc stock price (ITCI:XNAS), related news, valuation, dividends and more to help you make your investing decisions. The latest Intra-Cellular Therapies stock prices, stock quotes, news, and ITCI history to help you invest and trade smarter.
Research Intra-Cellular Therapies' (Nasdaq:ITCI) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth. UPDATE: Intra-Cellular Therapies stock soars 83% premarket after FDA approves schizophrenia treatment. Stock Quote. NASDAQ: ITCI. $ September 6, PM EDT. Change; 0 ( Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. Get the latest Intra-Cellular Therapies Inc. (ITCI) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Discover real-time Intra-Cellular Therapies Inc. Common Stock (ITCI) stock prices, quotes, historical data, news, and Insights for informed trading and. ITCI - Intra-Cellular Therapies, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS). The current price of ITCI is USD — it has decreased by −% in the past 24 hours. Watch Intra-Cellular Therapies Inc. stock price performance more. Intra-Cellular Therapies, Inc. is a biopharmaceutical company, which focuses on the discovery and clinical development of innovative, small molecule drugs. Intra-Cellular Therapies (ITCI) and Zentalis Pharmaceuticals, Inc. (ZNTL) are in the spotlight following pipeline and regulatory updates, respectively.
What is the analyst rating for ITCI? Currently, Wall Street analysts rate ITCI as Bullish on average. Additionally, the current consensus price target from. In the current month, ITCI has received 16 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ITCI average Analyst price target in the past 3 months is $ View Intra-Cellular Therapies (ITCI) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Intra-Cellular Therapies Inc. (ITCI) latest news: Q3 revenues rise to $M, CAPLYTA sales up 75%. Discover more about ITCI's innovative CNS. Track Intra-Cellular Therapies Inc (ITCI) Stock Price, Quote, latest community messages, chart, news and other stock related information.
RANGE BREAKOUT : ITCI STOCK ANALYSIS - INTRA CELLULAR THERAPIES STOCK